HOSPIRA INC 4
4 · HOSPIRA INC · Filed Nov 26, 2014
Insider Transaction Report
Form 4
HOSPIRA INCHSP
Yoskowitz Marc J
SVP, Strategy & Corporate Dev
Transactions
- Exercise/Conversion
Common Stock
2014-11-25$37.36/sh+11,523$430,499→ 43,146 total - Exercise/Conversion
Stock Options (right to buy)
2014-11-25+11,523→ 34,570 totalExercise: $37.36Exp: 2020-06-28→ Common Stock (11,523 underlying) - Sale
Common Stock
2014-11-25$59.93/sh−11,523$690,608→ 31,623 total
Footnotes (3)
- [F1]Exercise of derivative security exempted pursuant to Rule 16b-3.
- [F2]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $59.91 to $59.94, inclusive. The reporting person undertakes to provide to the Company, any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range of prices set forth in this footnote.
- [F3]The stock options, granted on June 28, 2013, vest in four equal annual installments on June 28, 2014, 2015, 2016, and 2017. The exercise price of $37.36 is the average of the high and low trading prices of Hospira common stock on the date of grant. The stock options have a seven-year term, which expire on June 28, 2020.